Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294


c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.

Gavert N, Shvab A, Sheffer M, Ben-Shmuel A, Haase G, Bakos E, Domany E, Ben-Ze'ev A.

Cancer Res. 2013 Sep 15;73(18):5754-63. doi: 10.1158/0008-5472.CAN-13-0576. Epub 2013 Sep 5.


Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.

Ben-Shmuel A, Shvab A, Gavert N, Brabletz T, Ben-Ze'ev A.

Oncogene. 2013 Jul 4;32(27):3220-30. doi: 10.1038/onc.2012.340. Epub 2012 Aug 6.


P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer.

Sun L, Hu H, Peng L, Zhou Z, Zhao X, Pan J, Sun L, Yang Z, Ran Y.

Am J Pathol. 2011 Jul;179(1):380-90. doi: 10.1016/j.ajpath.2011.03.046. Epub 2011 May 23.


Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.

Suman S, Kurisetty V, Das TP, Vadodkar A, Ramos G, Lakshmanaswamy R, Damodaran C.

Mol Carcinog. 2014 Feb;53 Suppl 1:E151-60. doi: 10.1002/mc.22076. Epub 2013 Sep 2.


L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.

Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze'ev A.

Mol Cancer Res. 2011 Jan;9(1):14-24. doi: 10.1158/1541-7786.MCR-10-0406. Epub 2010 Dec 1.


OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.

Dai X, Ge J, Wang X, Qian X, Zhang C, Li X.

Oncol Rep. 2013 Jan;29(1):155-60. doi: 10.3892/or.2012.2086. Epub 2012 Oct 17.


SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt/β-catenin pathway.

Tong X, Li L, Li X, Heng L, Zhong L, Su X, Rong R, Hu S, Liu W, Jia B, Liu X, Kou G, Han J, Guo S, Hu Y, Li C, Tao Q, Guo Y.

Oncotarget. 2014 Nov 15;5(21):10571-83.


A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.


Protein kinase C-δ-mediated recycling of active KIT in colon cancer.

Park M, Kim WK, Song M, Park M, Kim H, Nam HJ, Baek SH, Kim H.

Clin Cancer Res. 2013 Sep 15;19(18):4961-71. doi: 10.1158/1078-0432.CCR-13-0131. Epub 2013 Jul 23.


L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.

Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY.

Ann Surg Oncol. 2007 May;14(5):1703-11. Epub 2007 Jan 9.


Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.

Takahashi Y, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Anticancer Res. 2013 May;33(5):1927-34.


MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.

Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W.

Med Oncol. 2012 Jun;29(2):1037-43. doi: 10.1007/s12032-011-9975-z. Epub 2011 May 12.


Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.

Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T, Ben-Ze'ev A.

J Cell Sci. 2010 Jun 15;123(Pt 12):2135-43. doi: 10.1242/jcs.069542. Epub 2010 May 25.


Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.

Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT.

BMC Cancer. 2010 Aug 17;10:437. doi: 10.1186/1471-2407-10-437.


ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression.

Nam EH, Lee Y, Zhao XF, Park YK, Lee JW, Kim S.

Carcinogenesis. 2014 Feb;35(2):302-14. doi: 10.1093/carcin/bgt340. Epub 2013 Oct 15.


MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

Ji D, Chen Z, Li M, Zhan T, Yao Y, Zhang Z, Xi J, Yan L, Gu J.

Mol Cancer. 2014 Apr 23;13:86. doi: 10.1186/1476-4598-13-86.


miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.

Carcinogenesis. 2013 Nov;34(11):2443-51. doi: 10.1093/carcin/bgt206. Epub 2013 Jun 5.


Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases.

Bandapalli OR, Hariri N, Macher-Göppinger S, Kahlert C, Schirmacher P, Brand K.

Anticancer Res. 2011 Apr;31(4):1215-24.


Transcriptional profiling identifies genes induced by hepatocyte-derived extracellular matrix in metastatic human colorectal cancer cell lines.

Zvibel I, Wagner A, Pasmanik-Chor M, Varol C, Oron-Karni V, Santo EM, Halpern Z, Kariv R.

Clin Exp Metastasis. 2013 Feb;30(2):189-200. doi: 10.1007/s10585-012-9527-8. Epub 2012 Aug 29.


Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.

Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL, Yang YC.

Int J Cancer. 2014 Dec 1;135(11):2593-603. doi: 10.1002/ijc.28899. Epub 2014 Apr 23.

Supplemental Content

Support Center